Pharma-Bio Serv Past Earnings Performance
Past criteria checks 1/6
Pharma-Bio Serv's earnings have been declining at an average annual rate of -24.8%, while the Life Sciences industry saw earnings growing at 16.4% annually. Revenues have been declining at an average rate of 2.9% per year. Pharma-Bio Serv's return on equity is 4.3%, and it has net margins of 4.1%.
Key information
-24.8%
Earnings growth rate
-24.8%
EPS growth rate
Life Sciences Industry Growth | 21.5% |
Revenue growth rate | -2.9% |
Return on equity | 4.3% |
Net Margin | 4.1% |
Last Earnings Update | 31 Jan 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Pharma-Bio Serv makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Jan 24 | 15 | 1 | 4 | 0 |
31 Oct 23 | 17 | 1 | 4 | 0 |
31 Jul 23 | 18 | 2 | 4 | 0 |
30 Apr 23 | 18 | 1 | 4 | 0 |
31 Jan 23 | 19 | 1 | 4 | 0 |
31 Oct 22 | 19 | 1 | 4 | 0 |
31 Jul 22 | 20 | -4 | 9 | 0 |
30 Apr 22 | 21 | -2 | 9 | 0 |
31 Jan 22 | 21 | -2 | 9 | 0 |
31 Oct 21 | 20 | -2 | 9 | 0 |
31 Jul 21 | 20 | 3 | 4 | 0 |
30 Apr 21 | 21 | 1 | 4 | 0 |
31 Jan 21 | 21 | 2 | 4 | 0 |
31 Oct 20 | 22 | 2 | 4 | 0 |
31 Jul 20 | 21 | 2 | 4 | 0 |
30 Apr 20 | 20 | 2 | 5 | 0 |
31 Jan 20 | 20 | 2 | 4 | 0 |
31 Oct 19 | 20 | 2 | 4 | 0 |
31 Jul 19 | 20 | 2 | 5 | 0 |
30 Apr 19 | 20 | 2 | 5 | 0 |
31 Jan 19 | 19 | 2 | 5 | 0 |
31 Oct 18 | 18 | -1 | 5 | 0 |
31 Jul 18 | 13 | -2 | 4 | 0 |
30 Apr 18 | 13 | -3 | 4 | 0 |
31 Jan 18 | 13 | -3 | 4 | 0 |
31 Oct 17 | 13 | -1 | 5 | 0 |
31 Jul 17 | 17 | -1 | 5 | 0 |
30 Apr 17 | 17 | -1 | 6 | 0 |
31 Jan 17 | 19 | -1 | 6 | 0 |
31 Oct 16 | 20 | 0 | 6 | 0 |
31 Jul 16 | 21 | 1 | 6 | 0 |
30 Apr 16 | 22 | 1 | 6 | 0 |
31 Jan 16 | 22 | 2 | 6 | 0 |
31 Oct 15 | 23 | 2 | 6 | 0 |
31 Jul 15 | 25 | 2 | 6 | 0 |
30 Apr 15 | 25 | 2 | 6 | 0 |
31 Jan 15 | 26 | 2 | 6 | 0 |
31 Oct 14 | 28 | 2 | 6 | 0 |
31 Jul 14 | 29 | 3 | 6 | 0 |
30 Apr 14 | 31 | 3 | 6 | 0 |
31 Jan 14 | 32 | 5 | 6 | 0 |
31 Oct 13 | 33 | 5 | 6 | 0 |
31 Jul 13 | 32 | 5 | 5 | 0 |
Quality Earnings: PBSV has high quality earnings.
Growing Profit Margin: PBSV's current net profit margins (4.1%) are lower than last year (6.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PBSV's earnings have declined by 24.8% per year over the past 5 years.
Accelerating Growth: PBSV's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PBSV had negative earnings growth (-45.6%) over the past year, making it difficult to compare to the Life Sciences industry average (-6.6%).
Return on Equity
High ROE: PBSV's Return on Equity (4.3%) is considered low.